These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6516213)

  • 41. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dynamics of interferon in the rhinopharyngeal secretions of adults vaccinated with the NIVGRIP inactivated influenza vaccine by the nasal route].
    Jucu V; Steiner N; Petrescu A; Berevoianu T; Mihăilescu M; Berca C
    Virologie; 1986; 37(3):195-200. PubMed ID: 2429437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of influenza vaccination on the circulation of viruses in the respiratory tract of apparently healthy schoolchildren aged 7 to 14 years.
    Isaia G; Teodosiu O; Popescu G; Broniţki A; Sternberg I
    Virologie; 1982; 33(2):117-22. PubMed ID: 6293163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influenza vaccination in pediatric age.
    Esposito S; Principi N
    Expert Rev Vaccines; 2015 Jun; 14(6):785-7. PubMed ID: 25872557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review of intranasal influenza vaccine.
    Glueck R
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):203-11. PubMed ID: 11516789
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Assessment of the efficiency of vaccination against influenza (author's transl)].
    Ambrosch F; Wiedermann G
    Immun Infekt; 1976 Aug; 4(4):174-81. PubMed ID: 1017849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal immunization with inactivated influenza virus vaccine in a boys' boarding school.
    Briscoe JH
    Practitioner; 1975 Jun; 214(1284):821-6. PubMed ID: 1144287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiologic evaluation and labroatory characteristics of live influenza tissue vaccine for oral use].
    Mitchenko VP; Buruikova VI; Zharkova LD; Zakladnaia ZM; Poddubnyĭ FN
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):49-52. PubMed ID: 4454883
    [No Abstract]   [Full Text] [Related]  

  • 51. US authorities discourage use of nasal influenza vaccine, citing ineffectiveness.
    Furlow B
    Lancet Respir Med; 2017 Feb; 5(2):105-106. PubMed ID: 28145228
    [No Abstract]   [Full Text] [Related]  

  • 52. Oral immunization against influenza in children with asthma and chronic bronchitis.
    Bergmann KC; Waldman RH; Reinhöfer M; Pohl WD; Tischner H; Werchan D
    Adv Exp Med Biol; 1987; 216B():1685-90. PubMed ID: 3425455
    [No Abstract]   [Full Text] [Related]  

  • 53. The 2014-2015 influenza season: what you need to know.
    Campos-Outcalt D
    J Fam Pract; 2014 Sep; 63(9):532-3. PubMed ID: 25353025
    [No Abstract]   [Full Text] [Related]  

  • 54. Nasal application of inactivated influenza vaccine.
    Kimura M; Kuno-Sakai H; Takesue R; Ozaki K
    Acta Paediatr Jpn; 1988 Oct; 30(5):601-3. PubMed ID: 3144910
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results and prospects for vaccinal prevention of influenza].
    Smorodintsev AA; Aleksandrova GI
    Vopr Virusol; 1977; (3):259-71. PubMed ID: 333765
    [No Abstract]   [Full Text] [Related]  

  • 56. Oral route as method for immunizing against mucosal pathogens.
    Waldman RH; Stone J; Lazzell V; Bergmann KC; Khakoo R; Jacknowitz A; Howard S; Rose C
    Ann N Y Acad Sci; 1983 Jun; 409():510-6. PubMed ID: 6346997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Influenza vaccination. Position of the German Society for the Prevention fo Virus Diseases and the German Public Health Office].
    ZFA (Stuttgart); 1981 Oct; 57(30):2065. PubMed ID: 7314837
    [No Abstract]   [Full Text] [Related]  

  • 58. [Inactivated influenza vaccines].
    Andzhaparidze OG; Bektemirov TA
    Vopr Virusol; 1978; (5):520-32. PubMed ID: 366900
    [No Abstract]   [Full Text] [Related]  

  • 59. Trial of nasal influenza vaccine expands.
    Veggeberg S
    Mol Med Today; 1997 Nov; 3(11):468. PubMed ID: 9430778
    [No Abstract]   [Full Text] [Related]  

  • 60. UK stands by nasal flu vaccine for children as US doctors are told to stop using it.
    Hawkes N
    BMJ; 2016 Jun; 353():i3546. PubMed ID: 27354725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.